Bought more Climb Bio at $1.42/share. Now averaging $1.51/share.

Bought more Tullow Oil at 15.85p/share #TLW £TLW

Bought Harbour Energy at £2.276/share. #HBR £HBR

Sold at the same price.

Bought more Harbour Energy at £2.135/share. Now averaging £2.23/share #HBR £HBR

Bought Pliant Therapeutics at $1.35/share. #PLRX $PLRX

Bought even more Tullow Oil at 14.4p/share. £TLW

Bought more OPG Power Venture. Now average 4.8p/share. £OPG

Bought EVEN more Harbour Energy at £1.991/share. Now averaging £2.14/share #HBR £HBR

Bought EVEN more Harbour Energy at £1.902/share. Now averaging £2.07/share #HBR £HBR

Sold Focusrite at £1.80/share at a loss of 5.2%.

Sold Climb Bio at $1.36/share for a loss of 10%.

Sold Pliant Therapeutics at $1.66/share for a gain of 23%.

Sold Harbour Energy for £1.79/share, a loss of 13.5%.

Sold Immatics at $4.41/share at a loss of 7.3%.

Bought Focusrite at £1.72/share. £TUNE

Bought more of OPG Power Venture at 5.1p/share. £OPG

UK's Tullow Oil posts annual profit on lower impairments, asset revaluation gains #oott reuters.com/business/energ…

#TLW TULLOW OIL FY – 2025 forecast free cash flow of c.$100-200m at $70-80/bbl. Key focus is refinancing the Group’s capital structure

So, does that mean the whole business of Tullow Oil is worth roughly $1.5bn, net of tax without factoring in other assets that might boost its resources to over 700m barrels of oil? Obviously, without in-depth research into biz.